Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker

Marinel M. Ammenheuser, William E. Bechtold, Sherif Abdel-Rahman, Judah I. Rosenblatt, Darlene A. Hastings-Smith, Jonathan B. Ward

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

1,3-Butadiene (BD), which is used to make styrene-butadiene rubber, is a potent carcinogen in mice and a probable carcinogen, associated with leukemia, in humans. We have previously used HPRT mutation as a biomarker to evaluate exposures to BD in a monomer production plant. We now report on a study of 49 workers in a styrene-butadiene rubber plant in which we used the concentration of the BD metabolite 1,2-dihydroxy-4-(N-acetylcysteinyl-S)-butane (M1) in urine as a biomarker of exposure and the frequency of HPRT variant (mutant) lymphocytes (Vf) as a biomarker of effect. Workers were assigned to high- and low-exposure groups based on historical information about work areas and jobs. Personal exposure to BD for one work shift was measured using a passive badge dosimeter. Each participant provided a urine specimen and blood sample at the end of the work shift and completed a questionnaire providing information on lifestyle, health, and work activities. The average BD exposures in the high- and low-exposure groups were significantly different, even after excluding two extreme values, (high 1.48 ppm; low 0.15 ppm, p < 0.002). This study was done in 1994 and 1995 before the establishment, in 1996, of the new permissible exposure limit of 1 ppm. Both the mean M1 and the HPRTVf were more than three times greater in the high-exposure group than in the low-exposure group (p < 0.0005). The three end points correlated with each other, with sample correlation coefficients between 0.4 and 0.6. The correlations among BD exposure and the biomarkers of internal exposure and genotoxicity suggest that occupational exposure to BD, in the range of 1-3 ppm, may be associated with adverse biological effects.

Original languageEnglish (US)
Pages (from-to)1249-1255
Number of pages7
JournalEnvironmental Health Perspectives
Volume109
Issue number12
StatePublished - 2001

Fingerprint

Hypoxanthine Phosphoribosyltransferase
Lymphocytes
Biomarkers
biomarker
mutation
Polymers
polymer
Mutation
Carcinogens
Urine
carcinogen
Dosimeters
rubber
urine
Occupational Exposure
Metabolites
1,3-butadiene
exposure
Life Style
Leukemia

Keywords

  • Biological monitoring
  • Butadiene
  • HPRT mutations
  • Occupational health

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Ammenheuser, M. M., Bechtold, W. E., Abdel-Rahman, S., Rosenblatt, J. I., Hastings-Smith, D. A., & Ward, J. B. (2001). Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. Environmental Health Perspectives, 109(12), 1249-1255.

Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. / Ammenheuser, Marinel M.; Bechtold, William E.; Abdel-Rahman, Sherif; Rosenblatt, Judah I.; Hastings-Smith, Darlene A.; Ward, Jonathan B.

In: Environmental Health Perspectives, Vol. 109, No. 12, 2001, p. 1249-1255.

Research output: Contribution to journalArticle

Ammenheuser, MM, Bechtold, WE, Abdel-Rahman, S, Rosenblatt, JI, Hastings-Smith, DA & Ward, JB 2001, 'Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker', Environmental Health Perspectives, vol. 109, no. 12, pp. 1249-1255.
Ammenheuser, Marinel M. ; Bechtold, William E. ; Abdel-Rahman, Sherif ; Rosenblatt, Judah I. ; Hastings-Smith, Darlene A. ; Ward, Jonathan B. / Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. In: Environmental Health Perspectives. 2001 ; Vol. 109, No. 12. pp. 1249-1255.
@article{bb6f3c9f9c3a490cab0cb566b4565995,
title = "Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker",
abstract = "1,3-Butadiene (BD), which is used to make styrene-butadiene rubber, is a potent carcinogen in mice and a probable carcinogen, associated with leukemia, in humans. We have previously used HPRT mutation as a biomarker to evaluate exposures to BD in a monomer production plant. We now report on a study of 49 workers in a styrene-butadiene rubber plant in which we used the concentration of the BD metabolite 1,2-dihydroxy-4-(N-acetylcysteinyl-S)-butane (M1) in urine as a biomarker of exposure and the frequency of HPRT variant (mutant) lymphocytes (Vf) as a biomarker of effect. Workers were assigned to high- and low-exposure groups based on historical information about work areas and jobs. Personal exposure to BD for one work shift was measured using a passive badge dosimeter. Each participant provided a urine specimen and blood sample at the end of the work shift and completed a questionnaire providing information on lifestyle, health, and work activities. The average BD exposures in the high- and low-exposure groups were significantly different, even after excluding two extreme values, (high 1.48 ppm; low 0.15 ppm, p < 0.002). This study was done in 1994 and 1995 before the establishment, in 1996, of the new permissible exposure limit of 1 ppm. Both the mean M1 and the HPRTVf were more than three times greater in the high-exposure group than in the low-exposure group (p < 0.0005). The three end points correlated with each other, with sample correlation coefficients between 0.4 and 0.6. The correlations among BD exposure and the biomarkers of internal exposure and genotoxicity suggest that occupational exposure to BD, in the range of 1-3 ppm, may be associated with adverse biological effects.",
keywords = "Biological monitoring, Butadiene, HPRT mutations, Occupational health",
author = "Ammenheuser, {Marinel M.} and Bechtold, {William E.} and Sherif Abdel-Rahman and Rosenblatt, {Judah I.} and Hastings-Smith, {Darlene A.} and Ward, {Jonathan B.}",
year = "2001",
language = "English (US)",
volume = "109",
pages = "1249--1255",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "12",

}

TY - JOUR

T1 - Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker

AU - Ammenheuser, Marinel M.

AU - Bechtold, William E.

AU - Abdel-Rahman, Sherif

AU - Rosenblatt, Judah I.

AU - Hastings-Smith, Darlene A.

AU - Ward, Jonathan B.

PY - 2001

Y1 - 2001

N2 - 1,3-Butadiene (BD), which is used to make styrene-butadiene rubber, is a potent carcinogen in mice and a probable carcinogen, associated with leukemia, in humans. We have previously used HPRT mutation as a biomarker to evaluate exposures to BD in a monomer production plant. We now report on a study of 49 workers in a styrene-butadiene rubber plant in which we used the concentration of the BD metabolite 1,2-dihydroxy-4-(N-acetylcysteinyl-S)-butane (M1) in urine as a biomarker of exposure and the frequency of HPRT variant (mutant) lymphocytes (Vf) as a biomarker of effect. Workers were assigned to high- and low-exposure groups based on historical information about work areas and jobs. Personal exposure to BD for one work shift was measured using a passive badge dosimeter. Each participant provided a urine specimen and blood sample at the end of the work shift and completed a questionnaire providing information on lifestyle, health, and work activities. The average BD exposures in the high- and low-exposure groups were significantly different, even after excluding two extreme values, (high 1.48 ppm; low 0.15 ppm, p < 0.002). This study was done in 1994 and 1995 before the establishment, in 1996, of the new permissible exposure limit of 1 ppm. Both the mean M1 and the HPRTVf were more than three times greater in the high-exposure group than in the low-exposure group (p < 0.0005). The three end points correlated with each other, with sample correlation coefficients between 0.4 and 0.6. The correlations among BD exposure and the biomarkers of internal exposure and genotoxicity suggest that occupational exposure to BD, in the range of 1-3 ppm, may be associated with adverse biological effects.

AB - 1,3-Butadiene (BD), which is used to make styrene-butadiene rubber, is a potent carcinogen in mice and a probable carcinogen, associated with leukemia, in humans. We have previously used HPRT mutation as a biomarker to evaluate exposures to BD in a monomer production plant. We now report on a study of 49 workers in a styrene-butadiene rubber plant in which we used the concentration of the BD metabolite 1,2-dihydroxy-4-(N-acetylcysteinyl-S)-butane (M1) in urine as a biomarker of exposure and the frequency of HPRT variant (mutant) lymphocytes (Vf) as a biomarker of effect. Workers were assigned to high- and low-exposure groups based on historical information about work areas and jobs. Personal exposure to BD for one work shift was measured using a passive badge dosimeter. Each participant provided a urine specimen and blood sample at the end of the work shift and completed a questionnaire providing information on lifestyle, health, and work activities. The average BD exposures in the high- and low-exposure groups were significantly different, even after excluding two extreme values, (high 1.48 ppm; low 0.15 ppm, p < 0.002). This study was done in 1994 and 1995 before the establishment, in 1996, of the new permissible exposure limit of 1 ppm. Both the mean M1 and the HPRTVf were more than three times greater in the high-exposure group than in the low-exposure group (p < 0.0005). The three end points correlated with each other, with sample correlation coefficients between 0.4 and 0.6. The correlations among BD exposure and the biomarkers of internal exposure and genotoxicity suggest that occupational exposure to BD, in the range of 1-3 ppm, may be associated with adverse biological effects.

KW - Biological monitoring

KW - Butadiene

KW - HPRT mutations

KW - Occupational health

UR - http://www.scopus.com/inward/record.url?scp=0035683836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035683836&partnerID=8YFLogxK

M3 - Article

C2 - 11748032

AN - SCOPUS:0035683836

VL - 109

SP - 1249

EP - 1255

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 12

ER -